Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18439698 | MEDICATION ORDER PROCESSING AND RECONCILIATION | February 2024 | May 2025 | Abandon | 15 | 2 | 0 | Yes | No |
| 18413592 | PRESCRIPTION COMPATIBILITY CHECKING FOR A MEDICAL DEVICE | January 2024 | January 2025 | Allow | 12 | 1 | 0 | Yes | No |
| 18544892 | Apparatus for Recording Information Concerning the Use of an Injection Device | December 2023 | November 2024 | Allow | 11 | 1 | 0 | No | No |
| 18520496 | SYSTEM AND METHOD FOR RAPID AND ACCURATE HISTOLOGIC ANALYSIS OF TUMOR MARGINS USING MACHINE LEARNING | November 2023 | December 2024 | Allow | 13 | 1 | 0 | Yes | No |
| 18489074 | SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES | October 2023 | October 2024 | Allow | 12 | 2 | 0 | Yes | No |
| 18243211 | SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES | September 2023 | February 2025 | Allow | 17 | 1 | 1 | No | No |
| 18358713 | SYSTEMS AND METHODS FOR USE IN DIAGNOSING A MEDICAL CONDITION OF A PATIENT | July 2023 | February 2025 | Abandon | 19 | 2 | 0 | No | No |
| 18222580 | HEALTH CARE PRESCRIPTION SYNCHRONIZATION BETWEEN PATIENT AND HEALTH CARE PROVIDER | July 2023 | July 2024 | Allow | 12 | 2 | 0 | Yes | No |
| 18220897 | SYSTEMS AND METHODS FOR CONTAGIOUS ILLNESS SURVEILLANCE AND OUTBREAK DETECTION | July 2023 | June 2024 | Allow | 11 | 1 | 0 | No | No |
| 18316960 | SYSTEMS AND METHODS FOR AUTOMATED MEDICAL IMAGE ANALYSIS | May 2023 | March 2025 | Abandon | 22 | 2 | 0 | Yes | No |
| 17982812 | METHOD AND A SYSTEM FOR REAL TIME ANALYSIS OF RANGE OF MOTION (ROM) | November 2022 | April 2025 | Allow | 29 | 1 | 0 | Yes | No |
| 17891073 | SYSTEMS AND METHODS FOR PROVIDING DIGITAL HEALTH SERVICES | August 2022 | March 2025 | Allow | 31 | 2 | 0 | Yes | No |
| 17889653 | PRESCRIPTION ASSISTANCE DEVICE AND PRESCRIPTION ASSISTANCE METHOD | August 2022 | February 2025 | Allow | 30 | 1 | 0 | No | No |
| 17829708 | INFORMATION PROCESSING SYSTEM | June 2022 | March 2025 | Abandon | 34 | 2 | 0 | No | No |
| 17705585 | AUGMENTED ARTIFICIAL INTELLIGENCE SYSTEM AND METHODS FOR PHYSIOLOGICAL DATA PROCESSING | March 2022 | September 2023 | Abandon | 18 | 2 | 1 | No | No |
| 17690790 | GENERATING CANDIDATE APPOINTMENT SLOTS FROM APPOINTMENT CONSTRAINTS | March 2022 | October 2024 | Abandon | 32 | 1 | 0 | Yes | No |
| 17690857 | INVENTORY PREDICTION MANAGEMENT SYSTEM | March 2022 | December 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17688655 | SYSTEM AND METHOD FOR TRACKING A PORTION OF THE USER AS A PROXY FOR NON-MONITORED INSTRUMENT | March 2022 | April 2025 | Allow | 38 | 3 | 0 | No | No |
| 17651626 | MULTIMODAL BIOMARKERS PREDICTIVE OF TRANSDIAGNOSTIC SYMPTOM SEVERITY | February 2022 | March 2024 | Abandon | 25 | 3 | 1 | Yes | No |
| 17634469 | SYSTEM AND METHOD OF EVALUATING A SUBJECT USING A WEARABLE SENSOR | February 2022 | May 2025 | Abandon | 39 | 2 | 0 | No | No |
| 17588624 | DYNAMIC HOME THEMES FOR ASSISTED EARLY DETECTION AND TREATMENT IN HEALTHCARE | January 2022 | June 2025 | Allow | 41 | 3 | 0 | Yes | No |
| 17448283 | MEASUREMENT-FACILITATING DEVICE, METHOD, AND NON-TRANSITORY RECORDING MEDIUM THAT RECORDS PROGRAM | September 2021 | December 2024 | Abandon | 39 | 2 | 0 | No | No |
| 17465607 | System and Method for Providing Drive-Through Healthcare Services | September 2021 | April 2025 | Abandon | 44 | 2 | 1 | No | No |
| 17226636 | SYSTEMS, DEVICES, AND METHODS FOR EPISODE DETECTION AND EVALUATION | April 2021 | May 2025 | Allow | 49 | 3 | 0 | Yes | No |
| 17215156 | WORKSTATION ASSIGNMENT | March 2021 | December 2024 | Allow | 44 | 3 | 0 | Yes | No |
| 17186812 | SYSTEM AND METHOD FOR INTEGRATION OF TELEMEDICINE INTO MULTIMEDIA VIDEO VISITATION SYSTEMS IN CORRECTIONAL FACILITIES | February 2021 | November 2024 | Allow | 44 | 5 | 0 | Yes | No |
| 17181820 | METHOD FOR SAMPLE TEST COUNTING | February 2021 | April 2025 | Abandon | 50 | 4 | 0 | Yes | No |
| 17175808 | SYSTEMS AND METHODS FOR ASSIGNING EXAMS TO PHYSICIANS | February 2021 | December 2024 | Abandon | 46 | 2 | 1 | Yes | No |
| 17103608 | METHOD AND APPARATUS FOR IMPROVING BREATHING THERAPY COMPLIANCE | November 2020 | November 2024 | Abandon | 48 | 4 | 0 | Yes | No |
| 16785436 | SYSTEMS, METHODS, AND DEVICES FOR BIOPHYSICAL MODELING AND RESPONSE PREDICTION | February 2020 | June 2025 | Allow | 60 | 4 | 0 | Yes | Yes |
| 16531170 | SURGICAL INSTRUMENT MANAGEMENT SYSTEM | August 2019 | February 2025 | Abandon | 60 | 4 | 0 | Yes | Yes |
| 16305468 | METHODS AND APPARATUS FOR PREDICTING DEPRESSION TREATMENT OUTCOMES | November 2018 | December 2024 | Abandon | 60 | 6 | 1 | Yes | No |
| 16141459 | SYSTEM AND METHOD FOR AUTOMATED ENFORCEMENT OF POLICIES | September 2018 | July 2024 | Allow | 60 | 6 | 0 | Yes | No |
| 15090466 | PHARMACOGENETIC DRUG INTERACTION MANAGEMENT SYSTEM | April 2016 | January 2019 | Allow | 33 | 7 | 1 | Yes | Yes |
| 13826972 | BID-BASED REQUESTS FOR ELECTRONIC RESOURCES | March 2013 | August 2019 | Allow | 60 | 3 | 1 | Yes | Yes |
| 12709634 | USER-BASED HEALTH MONITORING | February 2010 | June 2011 | Allow | 16 | 1 | 0 | No | No |
| 12527188 | METHOD OF PROCESSING A RADON DATA BASED IMAGE FUNCTION AND IMAGING METHOD | December 2009 | August 2013 | Allow | 49 | 2 | 0 | No | No |
| 12615418 | METHOD AND SYSTEM FOR AUTOMATED INTERPRETATION OF COMPUTER TOMOGRAPHY SCAN DATA | November 2009 | May 2013 | Allow | 42 | 2 | 0 | Yes | No |
| 12272319 | EMERGENCY ALERT FEATURE ON A MOBILE COMMUNICATION DEVICE | November 2008 | June 2012 | Allow | 43 | 3 | 0 | Yes | No |
| 10593138 | EN-ROUTE NAVIGATION DISPLAY METHOD AND APPARATUS USING HEAD-UP DISPLAY | September 2008 | April 2013 | Allow | 60 | 2 | 1 | Yes | No |
| 12072240 | Method and system for managing delivery of content in a navigational environment | February 2008 | March 2015 | Allow | 60 | 4 | 0 | Yes | No |
| 11925100 | SYSTEM FOR COMMUNICATION OF HEALTH CARE DATA | October 2007 | August 2010 | Allow | 34 | 1 | 0 | Yes | No |
| 11977174 | METHODS AND SYSTEMS RELATED TO RECEIVING NUTRACEUTICAL ASSOCIATED INFORMATION | October 2007 | March 2011 | Allow | 41 | 1 | 0 | Yes | No |
| 11888613 | METHODS AND SYSTEMS RELATED TO TRANSMISSION OF NUTRACEUTICAL ASSOCIATED INFORMATION | July 2007 | August 2010 | Allow | 36 | 1 | 0 | Yes | No |
| 11824529 | COMPUTATIONAL SYSTEMS AND METHODS RELATED TO NUTRACEUTICALS | June 2007 | January 2019 | Allow | 60 | 8 | 0 | Yes | Yes |
| 11758716 | PATIENT DATA MINING FOR LUNG CANCER SCREENING | June 2007 | December 2013 | Allow | 60 | 7 | 0 | Yes | No |
| 11013927 | METHOD, SYSTEM, AND SOFTWARE FOR ANALYSIS OF A BILLING PROCESS | December 2004 | September 2011 | Allow | 60 | 2 | 0 | Yes | Yes |
| 11004134 | USER-BASED HEALTH MONITORING | December 2004 | January 2010 | Allow | 60 | 4 | 1 | Yes | No |
| 10956265 | SYSTEM AND METHOD FOR MEDICAL APPOINTMENT AND EXAMINATION SEQUENCE PLANNING | October 2004 | June 2010 | Allow | 60 | 3 | 0 | Yes | No |
| 10681954 | Method for storing and reporting pharmacy data | October 2003 | January 2014 | Allow | 60 | 4 | 0 | Yes | Yes |
| 10669132 | SYSTEMS AND METHODS FOR CONSUMERS TO PURCHASE HEALTH CARE AND RELATED PRODUCTS | September 2003 | December 2009 | Allow | 60 | 2 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner REYES, REGINALD R.
With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 22.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner REYES, REGINALD R works in Art Unit 3684 and has examined 49 patent applications in our dataset. With an allowance rate of 69.4%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.
Examiner REYES, REGINALD R's allowance rate of 69.4% places them in the 24% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by REYES, REGINALD R receive 2.76 office actions before reaching final disposition. This places the examiner in the 91% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by REYES, REGINALD R is 41 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +27.1% benefit to allowance rate for applications examined by REYES, REGINALD R. This interview benefit is in the 78% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 25.8% of applications are subsequently allowed. This success rate is in the 32% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 33.3% of cases where such amendments are filed. This entry rate is in the 42% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 54% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 60.0% of appeals filed. This is in the 31% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 100.0% are granted (fully or in part). This grant rate is in the 97% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 12.2% of allowed cases (in the 97% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 37% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.